Unraveling innovation potential in the real-world setting: eighteen novel agents with twenty-six approved European indications, in the management of leukemias, lymphomas, and multiple myeloma-Reference-Cited by-同舟云学术

Unraveling innovation potential in the real-world setting: eighteen novel agents with twenty-six approved European indications, in the management of leukemias, lymphomas, and multiple myeloma

Published:2019-09-24 Issue:12 Volume:12 Page:1063-1075
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Petrakis Ioannis¹,Kontogiorgis Christos¹,Nena Evangelia¹,Athanasakis Kostas²,Gougoula Vasiliki¹,Kotsianidis Ioannis³,Constantinidis Theodoros C.¹

Affiliation:

1. Laboratory of Hygiene and Environmental Protection, Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece

2. Department of Health Economics, National School of Public Health, Athens, Greece

3. Department of Hematology, University Hospital of Thrace, Alexandroupolis, Greece

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2019.1668763

Reference62 articles.

1. Drug discovery and therapeutic delivery for the treatment of B and T cell tumors

2. Meeting the global demands of epidemiologic transition - The indispensable role of cancer prevention

3. Diagnosis and classification of hematologic malignancies on the basis of genetics

4. Future cancer research priorities in the USA: a Lancet Oncology Commission

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does the Simultaneous Introduction of Several Pharmaceuticals in the Post-Lenalidomide Era Translate to Better Outcomes in Relapse Refractory Multiple Myeloma? Findings from the Real-World Innovation in Multiple Myeloma (REAL IMM) Study;Cancers;2023-12-14

2. Real-World Treatment of Patients With Relapsed/Refractory Myeloma;Clinical Lymphoma Myeloma and Leukemia;2021-06

3. Characteristics and survival trends in Finnish multiple myeloma patients—a nationwide real-world evidence study;Annals of Hematology;2021-03-12